AT372279B - Verfahren zur herstellung galenischer zubereitungen - Google Patents

Verfahren zur herstellung galenischer zubereitungen

Info

Publication number
AT372279B
AT372279B AT0803679A AT803679A AT372279B AT 372279 B AT372279 B AT 372279B AT 0803679 A AT0803679 A AT 0803679A AT 803679 A AT803679 A AT 803679A AT 372279 B AT372279 B AT 372279B
Authority
AT
Austria
Prior art keywords
galenic preparations
producing
producing galenic
preparations
galenic
Prior art date
Application number
AT0803679A
Other languages
German (de)
English (en)
Other versions
ATA803679A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA803679A publication Critical patent/ATA803679A/de
Application granted granted Critical
Publication of AT372279B publication Critical patent/AT372279B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0803679A 1978-12-21 1979-12-20 Verfahren zur herstellung galenischer zubereitungen AT372279B (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1302178 1978-12-21
CH1301978 1978-12-21
CH56679 1979-01-19
CH56779 1979-01-19

Publications (2)

Publication Number Publication Date
ATA803679A ATA803679A (de) 1983-02-15
AT372279B true AT372279B (de) 1983-09-26

Family

ID=27427929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0803679A AT372279B (de) 1978-12-21 1979-12-20 Verfahren zur herstellung galenischer zubereitungen

Country Status (23)

Country Link
AT (1) AT372279B (no)
AU (1) AU534051B2 (no)
CA (1) CA1139222A (no)
CH (1) CH642259A5 (no)
CY (1) CY1330A (no)
DE (1) DE2950154A1 (no)
DK (1) DK154607C (no)
FI (1) FI793888A (no)
FR (1) FR2444463A1 (no)
GB (1) GB2038181B (no)
HK (1) HK37986A (no)
HU (1) HU182577B (no)
IE (1) IE49323B1 (no)
IL (1) IL59003A (no)
IT (1) IT1164029B (no)
KE (1) KE3617D (no)
MY (1) MY8500129A (no)
NL (1) NL187229C (no)
NZ (1) NZ192457A (no)
PH (1) PH25178A (no)
PT (1) PT70614A (no)
SE (1) SE442265B (no)
WO (1) WO1980001242A1 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
CN1003978B (zh) * 1987-09-05 1989-04-26 广州陈李济药厂 一种补脾益肠丸的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung

Also Published As

Publication number Publication date
IT7951153A0 (it) 1979-12-20
CH642259A5 (de) 1984-04-13
DK154607C (da) 1989-06-05
FR2444463B1 (no) 1983-02-25
CY1330A (en) 1986-06-27
HK37986A (en) 1986-05-30
DK154607B (da) 1988-12-05
GB2038181A (en) 1980-07-23
PT70614A (fr) 1980-01-01
HU182577B (en) 1984-02-28
WO1980001242A1 (en) 1980-06-26
DE2950154C2 (no) 1989-05-11
GB2038181B (en) 1983-05-11
IE792471L (en) 1980-06-21
CA1139222A (en) 1983-01-11
IL59003A (en) 1982-12-31
IE49323B1 (en) 1985-09-18
ATA803679A (de) 1983-02-15
KE3617D (en) 1986-04-18
AU5403179A (en) 1980-06-26
FI793888A (fi) 1980-06-22
SE7910227L (sv) 1980-06-22
PH25178A (en) 1991-03-27
DE2950154A1 (de) 1980-07-10
AU534051B2 (en) 1984-01-05
DK529879A (da) 1980-06-22
NL7909105A (nl) 1980-06-24
IT1164029B (it) 1987-04-08
NL187229C (nl) 1991-07-16
FR2444463A1 (fr) 1980-07-18
MY8500129A (en) 1985-12-31
SE442265B (sv) 1985-12-16
NZ192457A (en) 1983-06-17

Similar Documents

Publication Publication Date Title
AT364451B (de) Verfahren zur herstellung von lokalanaesthetisch wirksamen kombinationspraeparaten
ATA729079A (de) Verfahren zur herstellung von monaldehyden
AT369366B (de) Verfahren zur herstellung von lysergol-derivaten
AT371097B (de) Verfahren zur herstellung von o-methallyloxyphenol
ATA311179A (de) Verfahren zur herstellung von 6alpha-halogen -pregnadien-derivates
AT374486B (de) Verfahren zur herstellung von 17beta-hydroxy-17
AT372279B (de) Verfahren zur herstellung galenischer zubereitungen
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT380701B (de) Verfahren zur herstellung von monofilen
ATA663779A (de) Verfahren zur herstellung von 3-exomethyl- encephamsulfoxidestern
AT363186B (de) Verfahren zur herstellung von glycosiden
AT369728B (de) Verfahren zur herstellung von trichloraethylen
AT374399B (de) Verfahren zur herstellung von ziehsteinbohrungen
AT367017B (de) Verfahren zur herstellung von p-amino-diphenylamin
AT369355B (de) Verfahren zur herstellung 2'-diaethylamino-1'methyl[thyl-2-hydroxy-2-cyclohexyl-oder -2-phenyl-cyclohexancarboxylat
AT372380B (de) Verfahren zur herstellung von 7-hydroxycumarinderivaten
AT371710B (de) Verfahren zur herstellung galenischer zubereitungen
AT376439B (de) Verfahren zur herstellung von ergotalkaloiden
AT370422B (de) Verfahren zur herstellung von vindesinmonosulfat
ATA254579A (de) Verfahren zur herstellung von 2-mercaptobenzthiazol
DD136833A1 (de) Verfahren zur herstellung von polyaetheralkoholen
AT357547B (de) Verfahren zur herstellung von 3-phenyl- pyridazon-(6)
AT370759B (de) Verfahren zur herstellung von bitumenpraeparaten
ATA136279A (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT366661B (de) Verfahren zur herstellung von cisbicyclooctylaminen